UK Discovery Major Step Forward In Treating Leukemia
Main Category: Lymphoma / Leukemia / MyelomaAlso Included In: Genetics
Article Date: 18 Jan 2008 - 2:00 PDT
'UK Discovery Major Step Forward In Treating Leukemia'
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
Researchers at the University of East Anglia have discovered for the first time a pathway that makes cancerous leukaemia cells resistant to treatment.
The scientists found that death-resistant Acute Myeloid Leukaemia cells are given their resistance by a genetic anti-oxidant pathway called hemeoxygenase-1 or HO-1. This resistance pathway leads to relapse of the disease and non-responsiveness to treatments. When this pathway is inhibited, the cells lose their resistance and become responsive to death-inducing agents.
Published online in the journal Blood on Friday January 18, the discovery is the first stage in the development of new drugs that could significantly improve survival rates for leukaemia sufferers.
"This is a major step forward in the treatment of leukaemia and other cancers," said Prof David MacEwan who led the research team.
"The next step will be a programme to develop a new set of targeted therapies to treat not only Acute Myeloid Leukaemia, but other leukaemias and other cancers."
Leukaemia is one of the six biggest cancer killers in the UK and more people die of Acute Myeloid Leukaemia (AML) than any other form of leukaemia. AML attacks the white blood cells and is a common form in both children and adults with leukaemia. It is currently treated by a range of chemotherapy drugs. Many patients go on to have bone marrow transplants due to commonly developing drug-resistance to their initial chemotherapy.
The antioxidant response element (ARE) genes which include HO-1, protect cells from damage and their killing off by cytotoxic agents such as chemotherapy drugs. The team found that drug-resistant leukaemia cells have overactive ARE genes that cause them to be completely resistant to cytotoxic drugs, and that blocking this pathway reverts the cells into responding normally to cytotoxic agents.
###
Source: Simon Dunford
University of East Anglia
Visit our lymphoma / leukemia / myeloma section for the latest news on this subject.
MLA
26 May. 2012. <http://www.medicalnewstoday.com/releases/94418.php>
APA
http://www.medicalnewstoday.com/releases/94418.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'UK Discovery Major Step Forward In Treating Leukemia'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





